New drug M6229 put to the test in healthy people
Knowledge-focused
Completed
This early-stage trial tested a new drug, M6229, in 15 healthy adults to see if it is safe and how the body processes it. Participants received either the drug or a placebo as a continuous 5-day infusion. The study is complete and focused on safety and drug levels, not on treatin…
Phase: PHASE1 • Sponsor: Matisse Pharmaceuticals • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC